NWRD09 for Persistent Cervical HPV16 Infection

NCT07710703 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Cervical HPV16 Infection

Interventions

BIOLOGICAL: NWRD09/ Placebo administered by IM injection

Sponsor

Newish Biotech (Wuxi) Co., Ltd.